Laddar...
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity
Though the pathophysiology of clinical obesity is undoubtedly multifaceted, several lines of clinical evidence implicate an important functional role for glucagon-like peptide 1 (GLP-1) signalling. Clinical studies assessing GLP-1 responses in normal weight and obese subjects suggest that weight gai...
Sparad:
| I publikationen: | World J Diabetes |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Baishideng Publishing Group Inc
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5155232/ https://ncbi.nlm.nih.gov/pubmed/28031776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v7.i20.572 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|